Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Insulin for COVID-19-related Smell Loss

NCT05461365 is registered in ClinicalTrials.gov with Universidad Panamericana as lead sponsor.

NCT NCT05461365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05461365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Insulin for COVID-19-related Smell Loss
Lead sponsor
Universidad Panamericana
Phase
Phase 3
Overall status
Completed
Start date
January 4, 2021
Completion date
December 20, 2021
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anosmia, covid-19, hyposmia, paraosmia, smell loss